{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:09:37Z","timestamp":1790665777399,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":2657,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health Awards","award":["HL81326"],"award-info":[{"award-number":["HL81326"]}]},{"name":"National Institutes of Health Awards","award":["HL58837"],"award-info":[{"award-number":["HL58837"]}]},{"name":"National Institutes of Health Awards","award":["HL101972"],"award-info":[{"award-number":["HL101972"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["AI088937"],"award-info":[{"award-number":["AI088937"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007804","name":"Oregon Clinical and Translational Research Institute","doi-asserted-by":"crossref","award":["UL1TR000128"],"award-info":[{"award-number":["UL1TR000128"]}],"id":[{"id":"10.13039\/100007804","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008143","name":"Oregon National Primate Research Center","doi-asserted-by":"crossref","award":["RR000163"],"award-info":[{"award-number":["RR000163"]}],"id":[{"id":"10.13039\/100008143","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1111\/jth.13005","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T10:18:06Z","timestamp":1431598686000},"page":"1383-1395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Factor XI and contact activation as targets for antithrombotic therapy"],"prefix":"10.1016","volume":"13","author":[{"given":"D.","family":"Gailani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Bane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13005_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00281-011-0288-2","article-title":"The procoagulant and proinflammatory contact system","volume":"3","author":"Renn\u00e9","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1111\/jth.13005_bb0015","series-title":"Metabolic and Molecular Bases of Inherited Disease","article-title":"J Emsley: factor XI and the plasma contact system","author":"Gailani","year":"2010"},{"issue":"Suppl. 1","key":"10.1111\/jth.13005_bb0020","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.thromres.2014.03.018","article-title":"Physiologic activities of the contact activation system","volume":"133","author":"Schmaier","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13005_bb0025","series-title":"Hematology: Basic Principles and Practice","first-page":"1939","article-title":"Rare coagulation factor deficiencies","author":"Gailani","year":"2010"},{"key":"10.1111\/jth.13005_bb0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1182\/blood.V10.2.120.120","article-title":"Plasma thromboplastin antecedent (PTA) deficiency: clinical, coagulation, therapeutic and hereditary aspects of a new hemophilia\u2010like disease","volume":"10","author":"Rosenthal","year":"1955","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0035","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1172\/JCI103109","article-title":"A familial hemorrhagic trait associated with a deficiency of a clot promoting fraction of plasma","volume":"34","author":"Ratnoff","year":"1955","journal-title":"J Clin Invest"},{"issue":"Suppl. 4","key":"10.1111\/jth.13005_bb0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/hae.12402","article-title":"Rare bleeding disorders \u2013 bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency","volume":"20","author":"James","year":"2014","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1111\/jth.13005_bb0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1538-7836.2009.03395.x","article-title":"Factor XI deficiency in humans","volume":"7","author":"Seligsohn","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/asheducation-2014.1.60","article-title":"Recent insights into the role of the contact pathway in thrombo\u2010inflammatory disorders","volume":"2014","author":"van Montfoort","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/jth.13005_bb0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1182\/asheducation-2014.1.66","article-title":"Epidemiologic and clinical data linking factors XI and XII to thrombosis","volume":"2014","author":"Key","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/jth.13005_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11239-011-0578-5","article-title":"The many faces of the contact pathway and their role in thrombosis","volume":"32","author":"Woodruff","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.13005_bb0065","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood-2009-09-199182","article-title":"Structure and function of factor XI","volume":"115","author":"Emsley","year":"2010","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1111\/jth.13005_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1538-7836.2009.03393.x","article-title":"Factor XI deficiency in animal models","volume":"7","author":"Renn\u00e9","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0075","article-title":"ISIS\u2010FXIRx, a novel and specific antisense inhibitor of factor XI, caused significant reduction in FXI antigen and activity and increased aPTT without causing bleeding in healthy volunteers","volume":"118","author":"Liu","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1405760","article-title":"Factor XI antisense oligonucleotide for prevention of venous thrombosis","volume":"372","author":"B\u00fcller","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13005_bb0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/asheducation-2014.1.52","article-title":"Future prospects for contact factors as therapeutic targets","volume":"2014","author":"Gailani","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/jth.13005_bb0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1101\/sqb.2009.74.001","article-title":"Step\u2010by\u2010step evolution of vertebrate coagulation","volume":"74","author":"Doolittle","year":"2009","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1111\/jth.13005_bb0095","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1538-7836.2008.03143.x","article-title":"Evolution of the contact phase of vertebrate blood coagulation","volume":"6","author":"Ponczek","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ygeno.2007.10.007","article-title":"Phylogenetic analysis of vertebrate kininogen genes","volume":"91","author":"Zhou","year":"2008","journal-title":"Genomics"},{"key":"10.1111\/jth.13005_bb0105","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1073\/pnas.76.10.4862","article-title":"Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain","volume":"76","author":"Thompson","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13005_bb0110","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1073\/pnas.74.10.4636","article-title":"Role of high\u2010molecular\u2010weight kininogen in surface\u2010binding and activation of coagulation Factor XI and prekallikrein","volume":"74","author":"Wiggins","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13005_bb0115","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood-2012-12-473629","article-title":"The dimeric structure of factor XI and zymogen activation","volume":"121","author":"Geng","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0120","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1016\/S0021-9258(20)89453-8","article-title":"Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces","volume":"266","author":"Naito","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13005_bb0125","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1126\/science.1652157","article-title":"Factor XI activation in a revised model of blood coagulation","volume":"253","author":"Gailani","year":"1991","journal-title":"Science"},{"key":"10.1111\/jth.13005_bb0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood-2010-10-312983","article-title":"Activation of factor XI by products of prothrombin activation","volume":"118","author":"Matafonov","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0135","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1073\/pnas.75.4.1998","article-title":"Role of surface in surface\u2010dependent activation of Hageman factor (blood coagulation Factor XII)","volume":"75","author":"Griffin","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13005_bb0140","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1538-7836.2010.03899.x","article-title":"Coagulation procofactor activation by factor XIa","volume":"8","author":"Whelihan","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0145","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/jth.12435","article-title":"Evidence of factor IX\u2010independent roles for factor XIa in blood coagulation","volume":"11","author":"Matafonov","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0150","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1182\/blood-2014-10-604587","article-title":"Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor","volume":"125","author":"Puy","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0155","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2516.2006.01304.x","article-title":"Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy","volume":"12","author":"Salomon","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13005_bb0160","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/jth.12600","article-title":"Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency","volume":"12","author":"Zucker","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0165","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1172\/JCI119412","article-title":"Thrombin\u2010mediated activation of factor XI results in thrombin\u2010activatable fibrinolysis inhibitor\u2010dependent inhibition of fibrinolysis","volume":"99","author":"von dem Borne","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13005_bb0170","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2174\/138955709789055216","article-title":"Recent developments in thrombin\u2010activatable fibrinolysis inhibitor research","volume":"9","author":"Marx","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"10.1111\/jth.13005_bb0175","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1160\/TH07-01-0051","article-title":"The dual role of the contact system in bacterial infectious disease","volume":"98","author":"Frick","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0180","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1038\/sj.emboj.7601422","article-title":"The contact system \u2013 a novel branch of innate immunity generating antibacterial peptides","volume":"25","author":"Frick","year":"2006","journal-title":"EMBO J"},{"key":"10.1111\/jth.13005_bb0185","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MOH.0000000000000069","article-title":"Polyphosphate: a new player in the field of hemostasis","volume":"21","author":"Smith","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/jth.13005_bb0190","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1182\/blood-2010-01-266791","article-title":"Polyphosphate exerts differential effects on blood clotting depending on polymer size","volume":"116","author":"Smith","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5482\/HAMO-13-01-0001","article-title":"Extracellular nucleic acids as novel alarm signals in the vascular system. Mediators of defence and disease","volume":"33","author":"Fischer","year":"2013","journal-title":"Hamostaseologie"},{"key":"10.1111\/jth.13005_bb0200","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.0608647104","article-title":"Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation","volume":"104","author":"Kannemeier","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13005_bb0205","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/ATVBAHA.114.304114","article-title":"Neutrophil extracellular traps promote thrombin generation through platelet\u2010dependent and platelet\u2010independent mechanisms","volume":"34","author":"Gould","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13005_bb0210","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2009.11.001","article-title":"Platelet polyphosphates are proinflammatory and procoagulant mediators in\u00a0vivo","volume":"139","author":"M\u00fcller","year":"2009","journal-title":"Cell"},{"key":"10.1111\/jth.13005_bb0215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","article-title":"Neutrophil extracellular traps promote deep vein thrombosis in mice","volume":"10","author":"Brill","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0220","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13005_bb0225","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1182\/blood-2011-07-368811","article-title":"Polyphosphate as a cofactor for the activation of factor XI by thrombin","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0230","article-title":"A role for coagulation factor XI and factor XII in DNA\u2010induced thrombin generation","volume":"124","author":"Matafonov","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0235","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/jth.12414","article-title":"Factor XI anion\u2010binding sites are required for productive interactions with polyphosphate","volume":"11","author":"Geng","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0240","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1182\/blood-2011-03-339572","article-title":"Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin","volume":"118","author":"Konings","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1172\/JCI781","article-title":"Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti\u2010fibrinolytic factor","volume":"101","author":"Minnema","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13005_bb0250","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9440(10)63989-2","article-title":"The characterization of mice with a targeted combined deficiency of protein c and factor XI","volume":"158","author":"Chan","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1111\/jth.13005_bb0255","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1055\/s-0037-1613081","article-title":"FXI is essential for thrombus formation following FeCl3\u2010induced injury of the carotid artery in the mouse","volume":"87","author":"Rosen","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0260","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1538-7836.2005.01236.x","article-title":"Effects of factor IX or factor XI deficiency on ferric chloride\u2010induced carotid artery occlusion in mice","volume":"3","author":"Wang","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0265","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2003-01-0324","article-title":"Factor XI\u2010dependence of surface\u2010 and tissue factor\u2010initiated thrombus propagation in primates","volume":"102","author":"Gruber","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0270","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.20050664","article-title":"Defective thrombus formation in mice lacking coagulation factor XII","volume":"202","author":"Renn\u00e9","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/jth.13005_bb0275","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2007-06-092338","article-title":"Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis","volume":"111","author":"Merkulov","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0280","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1182\/blood-2011-05-355248","article-title":"Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding","volume":"118","author":"Revenko","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0285","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1160\/TH11-10-0682","article-title":"Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher trait","volume":"107","author":"Bird","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0290","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1182\/blood-2014-01-550285","article-title":"Reduced thrombosis in Klkb1\u2010\/\u2010 mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor","volume":"125","author":"Stavrou","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0295","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1160\/TH10-05-0307","article-title":"Patients with severe factor XI deficiency have a reduced incidence of deep\u2010vein thrombosis","volume":"105","author":"Salomon","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0300","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM200003093421004","article-title":"High levels of coagulation factor XI as a risk factor for venous thrombosis","volume":"342","author":"Meijers","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13005_bb0305","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood-2009-05-219915","article-title":"Coagulation factors IX through XIII and the risk of future venous thrombosis: the longitudinal investigation of thromboembolism etiology","volume":"114","author":"Cushman","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0310","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1182\/blood-2007-10-120139","article-title":"Reduced incidence of ischemic stroke in patients with severe factor XI deficiency","volume":"111","author":"Salomon","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0315","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/QC259F09UNMKVP0R","article-title":"Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events","volume":"126","author":"Yang","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/jth.13005_bb0320","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000297966","article-title":"Novel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"29","author":"Suri","year":"2010","journal-title":"Cerebrovasc Dis"},{"key":"10.1111\/jth.13005_bb0325","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/CIRCULATIONAHA.110.943738","article-title":"Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) case\u2013control study","volume":"122","author":"Siegerink","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/jth.13005_bb0330","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1538-7836.2003.00195.x","article-title":"Inherited factor XI deficiency confers no protection against acute myocardial infarction","volume":"1","author":"Salomon","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0335","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2005-12-023697","article-title":"Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII","volume":"108","author":"Doggen","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0340","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1160\/TH07-08-0499","article-title":"Factor XIa and tissue factor activity in patients with coronary artery disease","volume":"99","author":"Butenas","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0049-3848(02)00190-1","article-title":"Elevated levels of Factor XI are associated with cardiovascular disease in women","volume":"107","author":"Berliner","year":"2002","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13005_bb0350","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/j.1538-7836.2007.02687.x","article-title":"The plasma kallikrein\u2010kinin system and risk of cardiovascular disease in men","volume":"5","author":"Govers\u2010Riemslag","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0355","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/j.1538-7836.2011.04508.x","article-title":"Factor XII gene mutation in the Hageman family","volume":"9","author":"Xu\u2010Cai","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0360","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1055\/s-0037-1614368","article-title":"Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency\u2013a study on 73 subjects from 14 Swiss families","volume":"82","author":"Zeerleder","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0365","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2141.1994.tb04937.x","article-title":"John Hageman's factor and deep\u2010vein thrombosis: Leiden Thrombophilia Study","volume":"87","author":"Koster","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13005_bb0370","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1538-7836.2007.02530.x","article-title":"Evidence of a U\u2010shaped association between factor XII activity and overall survival","volume":"5","author":"Endler","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0375","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/blood-2008-06-163675","article-title":"Prevention of vascular graft occlusion and thrombus\u2010associated thrombin generation by inhibition of factor XI","volume":"113","author":"Tucker","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0380","doi-asserted-by":"crossref","first-page":"38200","DOI":"10.1074\/jbc.M112.376343","article-title":"A sequential mechanism for exostie\u2010mediated factor IX activation by factor XIa","volume":"287","author":"Geng","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13005_bb0385","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2010-02-270918","article-title":"A role for factor XIIa\u2010mediated factor XI activation in thrombus formation in\u00a0vivo","volume":"116","author":"Cheng","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0390","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood-2013-04-499111","article-title":"Factor XII inhibition reduces thrombus formation in a primate thrombosis model","volume":"123","author":"Matafonov","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0395","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1182\/blood-2010-04-277798","article-title":"Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0400","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2011-10-387134","article-title":"Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys","volume":"119","author":"Younis","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0405","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/ATVBAHA.113.301282","article-title":"Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates","volume":"33","author":"Crosby","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13005_bb0410","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/j.1538-7836.2010.04021.x","article-title":"A dose\u2010ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in pa tients undergoing total knee arthroplasty","volume":"8","author":"Fuji","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0415","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1160\/TH09-11-0771","article-title":"Tissue factor and thrombosis: the clot starts here","volume":"104","author":"Owens","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0420","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0003-4975(97)01340-4","article-title":"Complement and contact activation during cardiovascular operations in infants","volume":"65","author":"Sonntag","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.13005_bb0425","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0162-3109(99)00067-3","article-title":"FXII levels, FXIIa\u2010like activities and kallikrein activities in normal subjects and patients undergoing cardiac surgery","volume":"45","author":"Wendel","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1111\/jth.13005_bb0430","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0022-5223(19)34156-X","article-title":"Blood activation during neonatal extracorporeal life support","volume":"105","author":"Pl\u00f6tz","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.13005_bb0435","doi-asserted-by":"crossref","first-page":"222ra17","DOI":"10.1126\/scitranslmed.3006804","article-title":"A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk","volume":"6","author":"Larsson","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1111\/jth.13005_bb0440","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood-2013-12-540872","article-title":"Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits","volume":"123","author":"Yau","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0445","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2014-05-577932","article-title":"Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis","volume":"124","author":"Travers","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0450","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1182\/blood-2012-07-444935","article-title":"Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation","volume":"120","author":"Smith","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0455","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1086\/589514","article-title":"Survival advantage of coagulation factor XI\u2010deficient mice during peritoneal sepsis","volume":"198","author":"Tucker","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/jth.13005_bb0460","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood-2011-10-386185","article-title":"Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis","volume":"119","author":"Tucker","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0465","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1128\/IAI.05568-11","article-title":"Factor XI\u2010deficient mice display reduced inflammation, coagulopathy, and bacterial growth during listeriosis","volume":"80","author":"Luo","year":"2012","journal-title":"Infect Immun"},{"key":"10.1111\/jth.13005_bb0470","doi-asserted-by":"crossref","first-page":"f5440","DOI":"10.1136\/bmj.f5440","article-title":"Secondary prevention of venous thromboembolism","volume":"347","author":"Schulman","year":"2013","journal-title":"BMJ"},{"key":"10.1111\/jth.13005_bb0475","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2013-12-512681","article-title":"Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism","volume":"123","author":"Kearson","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0480","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1109719","article-title":"Thrombin\u2010receptor antagonist vorapaxar in acute coronary syndromes","volume":"366","author":"Tricoci","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13005_bb0485","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(09)60738-8","article-title":"Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS\u2010TIMI 46): a randomised, double\u2010blind, phase II trial","volume":"374","author":"Mega","year":"2009","journal-title":"Lancet"},{"issue":"Suppl. 4","key":"10.1111\/jth.13005_bb0490","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2516.2004.00992.x","article-title":"New Observations on factor XI deficiency","volume":"10","author":"Salomon","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13005_bb0495","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13005_bb0500","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMe1310399","article-title":"Dabigatran and mechanical heart valves \u2013 not as easy as we hoped","volume":"369","author":"Hylek","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13005_bb0505","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1016\/j.bmcl.2006.07.043","article-title":"Synthesis and in\u00a0vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa","volume":"16","author":"Lazarova","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1111\/jth.13005_bb0510","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.bmcl.2006.02.052","article-title":"Synthesis, SAR exploration, and X\u2010ray crystal structures of factor XIa inhibitors containing an alpha\u2010ketothiazole arginine","volume":"16","author":"Deng","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1111\/jth.13005_bb0515","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11239-011-0599-0","article-title":"A small\u2010molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits","volume":"32","author":"Wong","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.13005_bb0520","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/jm401670x","article-title":"Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors","volume":"57","author":"Quan","year":"2014","journal-title":"J Med Chem"},{"key":"10.1111\/jth.13005_bb0525","doi-asserted-by":"crossref","first-page":"e0113705","DOI":"10.1371\/journal.pone.0113705","article-title":"Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design","volume":"10","author":"Fjellstr\u00f6m","year":"2015","journal-title":"PLoS One"},{"key":"10.1111\/jth.13005_bb0530","doi-asserted-by":"crossref","first-page":"9915","DOI":"10.1021\/jm5010607","article-title":"Phenylimidazoles as potent and selective inhibitors of coagulation factor XIa with in\u00a0vivo antithrombotic activity","volume":"57","author":"Hangeland","year":"2014","journal-title":"J Med Chem"},{"key":"10.1111\/jth.13005_bb0535","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/jm301338q","article-title":"Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa","volume":"56","author":"Al\u2010Horani","year":"2013","journal-title":"J Med Chem"},{"key":"10.1111\/jth.13005_bb0540","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1021\/jm500311e","article-title":"Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides","volume":"57","author":"Al\u2010Horani","year":"2014","journal-title":"J Med Chem"},{"key":"10.1111\/jth.13005_bb0545","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1021\/jm5002698","article-title":"Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors","volume":"57","author":"Argade","year":"2014","journal-title":"J Med Chem"},{"key":"10.1111\/jth.13005_bb0550","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood-2012-03-419523","article-title":"The kunitz protease inhibitor domain of protease nexin\u20102 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis","volume":"120","author":"Wu","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0555","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1021\/jm800314b","article-title":"Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa","volume":"51","author":"Buchanan","year":"2008","journal-title":"J Med Chem"},{"key":"10.1111\/jth.13005_bb0560","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/np500772u","article-title":"Total synthesis of clavatadine A","volume":"78","author":"Conn","year":"2015","journal-title":"J Nat Prod"},{"key":"10.1111\/jth.13005_bb0565","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1182\/blood-2013-08-517474","article-title":"Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in\u00a0vivo","volume":"122","author":"Ma","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13005_bb0570","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1021\/jm400236j","article-title":"A synthetic factor XIIa inhibitor blocks selectively intrinsic coagulation initiation","volume":"56","author":"Baeriswyl","year":"2013","journal-title":"J Med Chem"},{"key":"10.1111\/jth.13005_bb0575","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/jth.12302","article-title":"Inhibiting the intrinsic pathway of coagulation with a factor XII\u2010targeting RNA aptamer","volume":"11","author":"Woodruff","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13005_bb0580","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/CIRCULATIONAHA.109.924761","article-title":"Factor XIIa inhibitor recombinant human albumin Infestin\u20104 abolishes occlusive arterial thrombus formation without affecting bleeding","volume":"121","author":"Hagedorn","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/jth.13005_bb0585","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1160\/TH13-08-0668","article-title":"Factor XIIa inhibition by Infestin\u20104: in\u00a0vitro mode of action and in\u00a0vivo antithrombotic benefit","volume":"111","author":"Xu","year":"2014","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13005","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622045998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622045998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13005\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:12:05Z","timestamp":1761534725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622045998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":116,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1538783622045998"],"URL":"https:\/\/doi.org\/10.1111\/jth.13005","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factor XI and contact activation as targets for antithrombotic therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}